Today: 9 April 2026
Freeport-McMoRan stock jumps as copper hits a new record — what investors watch next
6 January 2026
1 min read

Freeport-McMoRan stock jumps as copper hits a new record — what investors watch next

NEW YORK, Jan 6, 2026, 09:51 EST — Regular session

Shares of Freeport-McMoRan Inc (FCX) rose 3.3% to $56.23 by 9:50 a.m. EST on Tuesday, after touching $57.12, a new 52-week high. The stock has traded between $55.71 and $57.12 so far, while rival Southern Copper was up about 3%.

Copper’s latest surge has been the key driver. Benchmark three-month copper on the London Metal Exchange (LME), a global pricing venue for industrial metals, hit a peak of $13,387.50 a metric ton on Tuesday, Reuters reported, citing a Morgan Stanley note.

Supply shocks and policy noise have amplified the rally. U.S. copper import tariffs remain under review, and inventories in Comex warehouses — tied to the U.S. futures exchange — climbed to 453,450 metric tons as of Jan. 2, up about 400% since April, Reuters reported. “Copper prices need to rise further to persuade miners to generate significant new production,” SP Angel analyst John Meyer said, though Macquarie analyst Alice Fox argued that “the fundamentals of the market do not justify current prices.” Reuters

But copper has a history of sharp pullbacks, and miners can fall fast when the metal turns. Any cooling in demand, a surprise jump in supply, or a shift in U.S. trade policy could cap the rally.

Freeport gained 4.78% on Monday to close at $54.41 and logged its second straight daily rise. Trading volume hit 26.7 million shares, nearly double its 50-day average, and the stock notched a new 52-week high, MarketWatch reported. MarketWatch

Stock Market Today

  • AbbVie's Humira Launch on TrumpRx with 86% Discount Sparks Valuation Questions
    April 9, 2026, 9:02 AM EDT. AbbVie (NYSE:ABBV) has introduced Humira on the TrumpRx platform at an 86% discount under a White House pricing deal aiming to reduce patient costs and widen drug access. This marks a significant US pricing strategy shift post exclusivity for Humira, a key immunology therapy driving substantial revenue. The stock trades near $206.69, about 20% below analyst targets and 43.8% under fair value estimates. The deep discount could alter patient volume, payer ties, and pricing benchmarks in government-linked drug programs. AbbVie's revenue exposure of $61.2 billion and a high price-to-earnings ratio of 87.3 place focus on potential impacts to cash flow and dividends amid its debt load. Investors should monitor reactions from payers, competitors, and capital markets to this pricing shift that could redefine AbbVie's US market dynamics.

Latest article

When Will Gas Prices Fall? Iran Ceasefire May Not Bring Quick Relief as Oil Rebounds

When Will Gas Prices Fall? Iran Ceasefire May Not Bring Quick Relief as Oil Rebounds

9 April 2026
Brent crude rebounded 3% Thursday despite a U.S.-Iran ceasefire, with the Strait of Hormuz still nearly shut and only one oil-products tanker passing in 24 hours. U.S. gasoline averaged $4.166 a gallon on April 9, and AAA said prices could drop slowly. North Sea Forties crude hit a record $146.43 a barrel. The U.S. EIA expects Hormuz flows may take months to recover.
CoreWeave Stock Climbs on $21 Billion Meta AI Cloud Deal, but Debt Risks Stay in Focus

CoreWeave Stock Climbs on $21 Billion Meta AI Cloud Deal, but Debt Risks Stay in Focus

9 April 2026
CoreWeave said Meta Platforms committed about $21 billion for AI cloud capacity through December 2032. Shares rose 4.3% to $88.90 in premarket trading after the announcement. The deal follows an $8.5 billion loan facility and a $1.25 billion senior notes offering. CoreWeave reported $5.13 billion in 2025 revenue and ended December with a $66.8 billion backlog.
NVIDIA’s Rubin AI Chip Ramp Hits Fresh Snag as HBM4 Memory Crunch Clouds 2026

NVIDIA’s Rubin AI Chip Ramp Hits Fresh Snag as HBM4 Memory Crunch Clouds 2026

9 April 2026
TrendForce said April 8 that Nvidia’s Rubin AI chip shipments may be delayed by HBM4 memory qualification and cooling demands, shifting over 70% of 2026 high-end GPU volume to the current Blackwell line. Rubin’s projected share dropped to 22%. Samsung began shipping HBM4 to Nvidia in February, but SK Hynix and Micron face qualification delays. Broadcom signed a long-term deal to develop Google’s TPUs through 2031.
Dow Jones today: DIA stock steadies near record as Fed’s Miran backs big rate cuts
Previous Story

Dow Jones today: DIA stock steadies near record as Fed’s Miran backs big rate cuts

AMD stock slips after CES AI chip push puts OpenAI deal back in focus
Next Story

AMD stock slips after CES AI chip push puts OpenAI deal back in focus

Go toTop